tiprankstipranks
Advertisement
Advertisement

MBX Stock Latest News

Analyst Reiterates Buy on MBX, Maintains $91 Price Target on Canvuparade’s Once-Weekly Hypoparathyroidism Opportunity
RatingsAnalyst Reiterates Buy on MBX, Maintains $91 Price Target on Canvuparade’s Once-Weekly Hypoparathyroidism Opportunity
1d ago
MBX
MBX Biosciences down 19% at $30.05 after announcing canvuparatide study results
PremiumThe Fly
MBX Biosciences down 19% at $30.05 after announcing canvuparatide study results
8d ago
MBX
MBX Biosciences unveils positive Phase 2 canvuparatide results
PremiumCompany Announcements
MBX Biosciences unveils positive Phase 2 canvuparatide results
8d ago
8K
MBX
MBX Biosciences announces results from Avail, canvuparatide trials
PremiumThe Fly
MBX Biosciences announces results from Avail, canvuparatide trials
8d ago
MBX
MBX Biosciences Shareholders Approve Directors and Auditor
PremiumCompany Announcements
MBX Biosciences Shareholders Approve Directors and Auditor
15d ago
8K
MBX
MBX Biosciences price target raised to $56 from $50 at Stifel
PremiumThe FlyMBX Biosciences price target raised to $56 from $50 at Stifel
1M ago
MBX
MBX Biosciences price target raised to $70 from $66 at Barclays
Premium
The Fly
MBX Biosciences price target raised to $70 from $66 at Barclays
1M ago
MBX
MBX Biosciences price target raised to $86 from $76 at Citizens
Premium
The Fly
MBX Biosciences price target raised to $86 from $76 at Citizens
1M ago
MBX
MBX Biosciences price target raised to $70 from $50 at Truist
PremiumThe Fly
MBX Biosciences price target raised to $70 from $50 at Truist
1M ago
MBX
MBX Biosciences Phase 1 data supports once-monthly dosing for MBX 4291
PremiumThe Fly
MBX Biosciences Phase 1 data supports once-monthly dosing for MBX 4291
1M ago
MBX
MBX Biosciences Highlights Positive Phase 1 Obesity Data
PremiumCompany Announcements
MBX Biosciences Highlights Positive Phase 1 Obesity Data
1M ago
8K
MBX
Advancing Pipeline and Key Data Catalysts Drive Analyst’s Bullish View on MBX
PremiumRatings
Advancing Pipeline and Key Data Catalysts Drive Analyst’s Bullish View on MBX
1M ago
MBX
MBX Biosciences reports Q1 EPS (51c), consensus (58c)
PremiumThe FlyMBX Biosciences reports Q1 EPS (51c), consensus (58c)
1M ago
MBX
MBX Biosciences appoints Mark Soued as chief commercial officer.
Premium
The Fly
MBX Biosciences appoints Mark Soued as chief commercial officer.
1M ago
MBX
ALNY
MBX Biosciences initiated with an Outperform at LifeSci Capital
Premium
The Fly
MBX Biosciences initiated with an Outperform at LifeSci Capital
3M ago
MBX
Options Volatility and Implied Earnings Moves Today, March 23, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 23, 2026
3M ago
LAR
MBX
MBX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
MBX Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3M ago
MBX
MBX Biosciences Advances Avail Phase 2 Trial in Hypoparathyroidism: What Investors Should Watch
PremiumCompany Announcements
MBX Biosciences Advances Avail Phase 2 Trial in Hypoparathyroidism: What Investors Should Watch
3M ago
MBX
MBX Biosciences files automatic mixed securities shelf
PremiumThe Fly
MBX Biosciences files automatic mixed securities shelf
3M ago
MBX
MBX Biosciences reports Q4 EPS (49c), consensus (63c)
PremiumThe FlyMBX Biosciences reports Q4 EPS (49c), consensus (63c)
3M ago
MBX
MBX Biosciences appoints Basbaum as Chief Business Officer
Premium
The Fly
MBX Biosciences appoints Basbaum as Chief Business Officer
3M ago
MBX
MBX Biosciences Advances Canvuparatide After Phase 2 FDA Meeting
Premium
Company Announcements
MBX Biosciences Advances Canvuparatide After Phase 2 FDA Meeting
3M ago
8K
MBX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >